| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 19.04B | 18.81B | 18.94B | 18.17B | 19.26B | 16.79B |
| Gross Profit | 7.12B | 6.89B | 6.71B | 5.67B | 6.06B | 5.33B |
| EBITDA | 6.43B | 6.74B | 6.70B | 8.38B | 8.01B | 7.16B |
| Net Income | 5.21B | 5.27B | 5.23B | 4.92B | 4.53B | 3.98B |
Balance Sheet | ||||||
| Total Assets | 68.29B | 66.75B | 62.75B | 60.25B | 57.48B | 60.58B |
| Cash, Cash Equivalents and Short-Term Investments | 14.87B | 14.50B | 12.68B | 11.22B | 10.18B | 10.01B |
| Total Debt | 4.83B | 4.57B | 3.72B | 3.43B | 3.92B | 2.28B |
| Total Liabilities | 16.74B | 16.15B | 15.96B | 15.71B | 16.20B | 21.79B |
| Stockholders Equity | 46.93B | 45.73B | 42.49B | 40.28B | 37.40B | 34.92B |
Cash Flow | ||||||
| Free Cash Flow | 2.95B | 3.46B | 3.07B | 3.44B | 3.28B | 70.57M |
| Operating Cash Flow | 5.79B | 5.86B | 5.15B | 6.15B | 6.23B | 2.75B |
| Investing Cash Flow | -3.74B | -3.45B | -38.54M | -1.98B | -795.42M | 1.97B |
| Financing Cash Flow | -3.23B | -1.88B | -3.03B | -3.05B | -4.69B | -2.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$63.69B | 7.14 | 11.51% | 5.34% | 1.02% | 0.36% | |
75 Outperform | HK$20.63B | 6.93 | 7.93% | 3.47% | 6.08% | 5.81% | |
73 Outperform | HK$66.33B | 5.50 | 5.92% | 5.72% | 12.77% | -18.46% | |
73 Outperform | HK$38.71B | 9.45 | 3.62% | 3.23% | 8.66% | 53.27% | |
69 Neutral | HK$4.43B | 3.20 | 4.48% | 6.69% | -14.81% | -3.39% | |
67 Neutral | HK$20.79B | 7.64 | 4.96% | 4.97% | 10.25% | -9.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |